American Society of Clinical Oncology

SHERPA: White

People

  1. Traina
    Traina
  2. Hudis
    Hudis
  3. Norton
    Norton
  4. Patil
    Patil
  5. Dickler
    Dickler
  6. Gucalp
    Gucalp
  7. Dang
    Dang
  8. Lake
    Lake
  9. Theodoulou-Haber
    Theodoulou-Haber
  10. Fornier
    Fornier

Groups

  1. Breast Medicine Service (72)
  2. Department of Medicine (72)
  3. Solid Tumor Oncology Division (72)
  4. Survivorship Research (72)
  5. Epidemiology and Biostatistics (30)
  6. Biostatistics Service (24)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (23)
  8. Population Sciences Research Program (18)
  9. GSK Faculty (12)
  10. Gynecologic Medicine Service (10)
Search Within
  1. "Survivorship Research"
  2. "Tiffany Traina"
Formats
  1. Meeting Abstract (61)
  2. Journal Article (10)
  3. Guidelines (1)
Groups
  1. Breast Medicine Service (72)
  2. Department of Medicine (72)
  3. Solid Tumor Oncology Division (72)
  4. Survivorship Research (72)
  5. Epidemiology and Biostatistics (30)
  6. Biostatistics Service (24)

More Groups

People
  1. Tiffany Traina (72)
  2. Clifford Hudis (37)
  3. Larry Norton (20)
  4. Sujata Patil (19)
  5. Ayca Gucalp (15)
  6. Maura Dickler (15)

More People

Years
  1. 2023 (4)
  2. 2022 (3)
  3. 2021 (4)
  4. 2020 (2)
  5. 2019 (4)
  6. 2018 (5)

More Years

Publications
  1. Journal of Clinical Oncology (71)
  2. JCO Precision Oncology (1)

Results (72)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The ARETHA study: A phase 2 randomized control trial of eribulin with evexomostat (SDX-7320) or placebo for patients with metastatic triple-negative breast cancer (TNBC) and metabolic dysfunction
    Meeting Abstract

    Shen, S.; Solomon, V.; Williams, D.; Robson, M. E.; Norton, L.; Traina, T. A.; Iyengar, N. M.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Enhancing patient clinical streamlining (EPACS) pilot in the breast medicine service at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Amel Riazat-Kesh, Y. J. R.; Miceli, M. R.; Smith, A.; Keenan, K.; Morrison, J.; Magnoli, R.; Strong, V. E.; Traina, T. A.; Sanford, R. A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Prospective evaluation of pathologic response with neoadjuvant chemo-immunotherapy in metaplastic breast cancer
    Meeting Abstract

    Abuhadra, N.; Chen, Y.; Plitas, G.; Razavi, P.; Pareja, F.; Reis-Filho, J. S.; Wen, H. Y.; Khan, A. J.; Traina, T. A.; Downs-Canner, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • State-of-the-art management of HER2-negative early breast cancer: Treatment patterns among healthcare professionals and concordance with expert recommendations
    Meeting Abstract

    Becker, M. N.; Abraham, J.; Kalinsky, K.; Spring, L.; Traina, T. A.; Quill, T. A.; Yardley, D. A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Oral minoxidil for the treatment of late alopecia in cancer survivors
    Meeting Abstract

    Kuo, A. M. S.; Reingold, R. E.; Ketosugbo, K.; Pan, A.; Dusza, S. W.; Kraehenbuehl, L.; Gajria, D.; Lake, D. E.; Bromberg, J.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Adjuvant palbociclib for ER+ breast cancer (PALLAS Trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13): A preplanned analysis of the stage IIA cohort
    Meeting Abstract

    DeMichele, A.; Dueck, A. C.; Hlauschek, D.; Martin, M.; Burstein, H. J.; Pfeiler, G.; Zdenkowski, N.; Wolff, A. C.; Balic, M.; Miller, K.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Treatment exposure and discontinuation in the PALbociclib CoLlaborative Adjuvant Study of palbociclib with adjuvant endocrine therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03)
    Journal Article

    Mayer, E. L.; Fesl, C.; Hlauschek, D.; Garcia-Estevez, L.; Burstein, H. J.; Zdenkowski, N.; Wette, V.; Miller, K. D.; Balic, M.; Mayer, I. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Outcomes in patients (pts) aged ≥ 65 years in the phase 3 ASCENT study of sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC)
    Meeting Abstract

    Kalinsky, K.; Oliveira, M.; Traina, T. A.; Tolaney, S. M.; Loirat, D.; Punie, K.; Hurvitz, S. A.; Lynce, F.; Hamilton, E. P.; Nanda, R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Phase Ib/II study of capecitabine 7/7 schedule with neratinib in patients with HER2-positive metastatic breast cancer (MBC)
    Meeting Abstract

    Wang, R.; Singh, J. C.; Wong, S. T. L.; Lake, D.; Iyengar, N. M.; D'Andrea, G.; Brockway-Marchello, J. P.; Kaba, A.; Traina, T. A.; Robson, M. E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Provision of subspecialized expert oncology (SEO) opinions using Navya Cancer Data Model (NCDM), a technology-based platform: Prospective study to facilitate access to care
    Meeting Abstract

    Traina, T. A.; Kantoff, P. W.; Matasar, M. J.; Dunn, L.; Friedman, C. F.; Voss, M. H.; Seidman, A. D.; Cahlon, O.; Zauderer, M. G.; Manship, C.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save